KLP Kapitalforvaltning AS acquired a new stake in Waters Co. (NYSE:WAT - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 19,792 shares of the medical instruments supplier's stock, valued at approximately $7,342,000.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Wealthfront Advisers LLC boosted its position in Waters by 106,144.4% during the fourth quarter. Wealthfront Advisers LLC now owns 3,087,461 shares of the medical instruments supplier's stock valued at $1,145,386,000 after buying an additional 3,084,555 shares during the period. Madison Investment Advisors LLC purchased a new stake in Waters during the 4th quarter valued at about $104,645,000. Principal Financial Group Inc. grew its position in Waters by 70.7% during the 3rd quarter. Principal Financial Group Inc. now owns 656,019 shares of the medical instruments supplier's stock worth $236,095,000 after acquiring an additional 271,804 shares during the last quarter. Thrivent Financial for Lutherans increased its stake in Waters by 7,120.8% in the 4th quarter. Thrivent Financial for Lutherans now owns 189,401 shares of the medical instruments supplier's stock worth $70,264,000 after purchasing an additional 186,778 shares during the period. Finally, Proficio Capital Partners LLC bought a new stake in Waters in the fourth quarter valued at approximately $42,114,000. Institutional investors own 94.01% of the company's stock.
Waters Stock Performance
Shares of Waters stock opened at $373.07 on Tuesday. The business has a fifty day simple moving average of $390.29 and a two-hundred day simple moving average of $371.85. The firm has a market capitalization of $22.16 billion, a P/E ratio of 34.83, a P/E/G ratio of 3.79 and a beta of 1.00. The company has a current ratio of 0.94, a quick ratio of 0.65 and a debt-to-equity ratio of 1.14. Waters Co. has a 12 month low of $279.24 and a 12 month high of $423.56.
Waters (NYSE:WAT - Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, topping the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. On average, equities analysts forecast that Waters Co. will post 12.86 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on WAT. JPMorgan Chase & Co. raised their target price on shares of Waters from $380.00 to $390.00 and gave the stock a "neutral" rating in a report on Thursday, March 6th. Scotiabank upgraded shares of Waters from a "sector perform" rating to a "sector outperform" rating and boosted their price objective for the company from $430.00 to $450.00 in a research report on Thursday, February 13th. StockNews.com lowered shares of Waters from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th. Sanford C. Bernstein raised Waters from a "market perform" rating to an "outperform" rating and set a $430.00 target price on the stock in a research note on Friday, January 10th. Finally, UBS Group upped their price target on Waters from $405.00 to $410.00 and gave the company a "neutral" rating in a research report on Thursday, February 13th. Eleven analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $391.07.
Check Out Our Latest Report on Waters
Waters Company Profile
(
Free Report)
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
See Also
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Waters, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Waters wasn't on the list.
While Waters currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.